About the Authors
- Brooke H. Miller
-
Affiliation Department of Neuroscience, The Scripps Research Institute-Scripps Florida, Jupiter, Florida, United States of America
- Laura E. Schultz
-
Affiliation Department of Molecular Therapeutics, The Scripps Research Institute-Scripps Florida, Jupiter, Florida, United States of America
- Anisha Gulati
-
Affiliation Department of Molecular Therapeutics, The Scripps Research Institute-Scripps Florida, Jupiter, Florida, United States of America
- Andrew I. Su
-
Affiliation Genomic Institute of the Novartis Research Foundation, San Diego, California, United States of America
- Mathew T. Pletcher
-
* E-mail: Mathew.Pletcher@pfizer.com
Current address: Compound Safety Prediction, Pfizer Global Research and Development, Groton, Connecticut, United States of America
Affiliation Department of Molecular Therapeutics, The Scripps Research Institute-Scripps Florida, Jupiter, Florida, United States of America
Competing Interests
Although the corresponding author is currently employed by a commercial entity, all of the work described in this paper was conducted prior to employment at Pfizer Global Research and Development. Pfizer provided no funding in support of this work other than covering publication fees. There are no competing interests in relation to this current employment status. Andrew Su is employed by the Genomics Institute of the Novartis Research Foundation, but this does not alter the authors' adherence to the PLOS ONE policy on data sharing. The Genomics Institute of the Novartis Research Foundation provided no direct funding for this work or publication and did not play a role in any decisions regarding this work or publication.
Author Contributions
Conceived and designed the experiments: BHM MTP. Performed the experiments: BHM LES AG MTP. Analyzed the data: BHM MTP. Contributed reagents/materials/analysis tools: AIS. Wrote the paper: BHM MTP.